Results 101 to 110 of about 1,627,676 (310)

Type 2 Diabetes and Sarcopenia

open access: yesApollo Medicine
Sarcopenia, which is defined as an age-related decline in muscle mass and strength, has been found to have a strong bidirectional relationship with Type 2 diabetes.
Samantha Sathyakumar
doaj   +1 more source

Individualizing treatment of type 2 diabetes

open access: yesSri Lanka Journal of Diabetes Endocrinology and Metabolism, 2014
DOI: http://dx.doi.org/10.4038/sjdem.v4i1.7256 Sri Lanka Journal of Diabetes, Endocrinology and Metabolism 2014; 4: 56 ...
TP Weerarathna
doaj   +1 more source

Chronobiology of Cancer: How Aging Fuels Oncogenesis at the Molecular Level

open access: yesAging and Cancer, EarlyView.
This graphical abstract illustrates the key biological pathways linking aging with cancer development and progression. In the upper left, cumulative exposure to ultraviolet radiation, toxins, and reactive oxygen species (ROS) causes DNA damage and genomic instability, whereas age‐related decline in repair mechanisms, such as ATM/ATR, BER, and NER ...
Anu Singh, Aroonima Misra, Sufian Zaheer
wiley   +1 more source

The impact of type 2 diabetes and Microalbuminuria on future cardiovascular events in patients with clinically manifest vascular disease from the Second Manifestations of ARTerial Disease (SMART) study [PDF]

open access: yes, 2008
Aims Type 2 diabetes mellitus and microalbuminuria are important risk factors for cardiovascular disease (CVD). Whether these two complications are important and independent risk factors for future CVD events in a high-risk population with clinically ...
Graaf, Y., van der   +4 more
core   +1 more source

Six-year Follow-Up of Nonpharmacological and Nonsurgical Obesity Treatments

open access: yesDiabetes, Metabolic Syndrome and Obesity
Maja J Ekman,1 Martin Ridderstråle1,2 1Department of Clinical Sciences Malmö, Clinical Obesity Research, Lund University, Skåne University Hospital, Malmö, Sweden; 2Department of Translational Type 2 Diabetes Research, Steno Diabetes Center Copenhagen ...
Ekman MJ, Ridderstråle M
doaj  

Nephropathy in type 2 diabetes [PDF]

open access: yesJournal of Internal Medicine, 1999
End‐stage renal failure (ESRF) in diabetic patients, mostly type 2, has become the most frequent cause of renal replacement therapy in western Europe. The majority of patients with type 2 diabetes and renal failure suffer from diabetic glomerulosclerosis, but non‐diabetic renal disease and atypical presentations, e.g.
openaire   +2 more sources

A Prospective Study of Individuals at Risk of Multiple Sclerosis Informs the Design of Primary Prevention Studies

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective In multiple sclerosis, the optimal time for deploying a therapeutic intervention is before the central nervous system is damaged; given the success of trials treating the earliest stage of MS, the radiologically isolated syndrome, developing primary prevention strategies is an important next challenge.
Amy W. Laitinen   +7 more
wiley   +1 more source

A randomized trial of selenium supplementation and risk of type-2 diabetes, as assessed by plasma adiponectin [PDF]

open access: yes, 2012
Background: Evidence that selenium affects the risk of type-2 diabetes is conflicting, with observational studies and a few randomized trials showing both lower and higher risk linked to the level of selenium intake and status. We investigated the effect
Steinbrenner, Holger   +31 more
core   +1 more source

Type 2 diabetes [PDF]

open access: yesThe Lancet, 2018
Remy, Boussageon   +4 more
openaire   +4 more sources

Type 2 diabetes: the emerging epidemic

open access: yesSouth African Family Practice, 2007
This article reports on the prevalence of diabetes in South Africa and gives projections for the epidemic proportions that this disease may take by the year 2030.
Paul Rheeder
doaj   +1 more source

Home - About - Disclaimer - Privacy